Pharmacy Times

DECEMBER 30, 2024

The disparity highlights opportunities for pharmacists to get involved and address health disparities.

Scheduling Appointments 115

Scheduling Appointments 115

The Checkup by Singlecare

DECEMBER 30, 2024

Sold under brand names such as Amvaz, Katerzia, Norliqva, and Norvasc , amlodipine is a medication that is FDA approved for the treatment of hypertension (high blood pressure), chronic stable angina (chest pain and pressure), vasospastic angina (coronary artery spasm), and coronary artery disease. It belongs to a class of medications called calcium channel blockers, which is further broken down into two classes: dihydropyridine calcium channel blockers and nondihydropyridine calcium channel bloc

Hospitals 98

Hospitals FDA 98

Drug Topics

DECEMBER 28, 2024

Check out this list of our top 5 most read infectious disease stories from the year 2024.

200

200

STAT

DECEMBER 27, 2024

A woman sat in our emergency department in agonizing pain, feeling shaky, nauseous, and weak — drug withdrawal was setting in. But she wasn’t a “junkie” or even a recreational drug user. She was in her mid-60s with advanced cancer in her ovaries that had spread to her abdomen, causing unbearable pain. She was my patient — let’s call her Teresa.

145

145

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

DECEMBER 27, 2024

Individuals who refused a pneumococcal vaccine were associated with low collective responsibility and confidence in vaccine efficacy and safety.

Vaccines 132

Vaccines Immunization 132

pharmaphorum

DECEMBER 27, 2024

WuXi AppTec has agreed to sell a business unit serving the cell and gene therapy (CGT) sector to private equity firm Altaris for an undisclosed sum

104

104

STAT

DECEMBER 30, 2024

Although bipartisan legislation to provide Medicare coverage for obesity treatments has circulated in Congress for more than a decade, the Congressional Budget Office (CBO) ventured to  estimate  the budgetary effects of such a policy for older Americans starting in 2026 for the very first time in a report published in October.  The CBO should be commended for conducting this comprehensive analysis.

100

100

Pharmacy Times

DECEMBER 27, 2024

Muvalaplin is an oral, small molecule inhibitor that can reduce lipoprotein(a).

132

132

Med Ed 101

JANUARY 1, 2025

I’ve compiled this YouTube video to help candidates best prepare for their 2025 BCPS pharmacy exam. Pass rates continue to be in the 60% range so it is difficult to pass this exam. There are significant changes this year in the 2025 BCPS Exam compared to last spring. The content outline has shifted significantly. Here […] The post 2025 BCPS Pharmacy Exam – What You Need To Know appeared first on Med Ed 101.

75

75

pharmaphorum

DECEMBER 31, 2024

Sangamo is 'surprised and disappointed' by Pfizer's decision to return rights to its gene therapy for haemophilia A after positive phase 3 results

101

101

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Topics

JANUARY 1, 2025

Check out this list of our top 5 most read immunization stories from the year 2024.

Immunization 98

Immunization 98

STAT

DECEMBER 30, 2024

Work by device manufacturers to improve the performance of pulse oximeters on people with darker skin has progressed little since the Food and Drug Administration asked manufacturers in 2013 to voluntarily test the devices on more diverse skin tones, according to a study published Monday in JAMA. The study and a related editorial suggest clearer guidance, enforcement, and possibly legal action may be necessary to ensure the devices work well on all skin tones.

Documentation 109

Documentation FDA 109

Pharmacy Times

DECEMBER 27, 2024

Federal legislation would seek to foster development of antibiotics.

132

132

Pharma Marketing Network

DECEMBER 31, 2024

Table of Contents Sr# Headings 1 Introduction: The Pharma Marketing Challenge 2 Building a Winning Pharma Marketing Strategy 3 The Role of Branded Drug Campaigns 4 Innovating for Future Success Introduction: The Pharma Marketing Challenge Marketing pharmaceuticals is no small feat. In an industry where lives are at stake, creating compelling, compliant, and effective campaigns can feel like walking a tightrope.

FDA 52

FDA 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

DECEMBER 30, 2024

BMS beats MSD to the US subcutaneous PD-1 inhibitor market after Opdivo Qvantiq is cleared across nearly all the indications of the IV form

93

93

Drug Topics

DECEMBER 31, 2024

Check out this list of our top 5 most read nonopioid pain management stories from the year 2024.

98

98

STAT

DECEMBER 30, 2024

Axsome Therapeutics is moving ahead with plans to submit its Alzheimer’s disease treatment for Food and Drug Administration approval despite mixed results from two new clinical trial readouts.  Axsome, which is based in New York, announced Monday that its drug AXS-05 met the primary endpoint of one trial testing the therapy for agitation caused by Alzheimer’s, but failed to show statistical significance in another.

FDA 92

FDA 92

Pharmacy Times

DECEMBER 27, 2024

The program develops patient-centered oncology pharmacists through comprehensive training.

123

123

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

The Checkup by Singlecare

DECEMBER 26, 2024

2024 has been a busy year for new drugs. Over 40 new medications have been approved by the FDA, giving patients more options for treating various health problems. These new drugs cover a wide range of conditions, from urinary tract infections to rare genetic disorders. Notable new drugs approved in 2024 By staying up-to-date on the latest drug approvals, pharmacists can give new advice when working with patients and other healthcare providers.

FDA 52

FDA Dosage Immunization Hospitals 52

pharmaphorum

DECEMBER 30, 2024

Daiichi Sankyo has claimed its first approval, in Japan, for TROP2-targeting antibody-drug conjugate (ADC) datopotamab deruxtecan

70

70

Drug Topics

DECEMBER 31, 2024

Check out this list of our top 5 most read obesity stories from the year 2024.

98

98

Pharmaceutical Technology

JANUARY 2, 2025

Effective management of atopic dermatitis (AD) has been one of the top priorities for physicians over the years, as quality of life in these patients is compromised due to the disruptive symptoms that they experience, which include itchiness and skin inflammation.

59

59

Pharmacy Times

DECEMBER 28, 2024

Study results show that the updated BNT162b2 XBB vaccine is effective in preventing hospitalizations or emergency department visits associated with COVID-19 complications.

Hospitals 123

Hospitals Vaccines 123

Hospital Pharmacy Europe

DECEMBER 30, 2024

A study looking at the use of potentially inappropriate medications (PIMs) in hospitalised adults aged75 and over has highlighted the need for multidisciplinary interventions to review chronic medications in these patients. The study found that the overall prevalence of PIMs was moderate but varied considerably between hospitals and also revealed a potential missed opportunity to optimise medication use within this setting.

Hospitals 52

Hospitals 52

pharmaphorum

DECEMBER 31, 2024

Phase 3 results with an intrathecal version of Novartis spinal muscular atrophy (SMA) gene therapy could make older children eligible for treatment.

65

65

Drug Topics

DECEMBER 30, 2024

Check out this list of our top 5 most read diabetes stories from the year 2024.

98

98

Pharmaceutical Technology

JANUARY 2, 2025

HUTCHMED (China) has entered into agreements to sell a 45% equity interest in Shanghai Hutchison Pharmaceuticals (SHPL)

59

59

Pharmacy Times

DECEMBER 26, 2024

High levels of the Oscillibacter genus of bacteria were associated with reduced cholesterol.

123

123

The Checkup by Singlecare

DECEMBER 30, 2024

Soma, the brand name for the generic medication Carisoprodol, is a muscle relaxant given to those with pain related to musculoskeletal conditions. The prescription drug is part of the skeletal muscle relaxant class of medications. Due to the risk of substance abuse on this medicine, some may wonder if Soma is considered a controlled substance. We went to the medical experts to learn everything you want to know about Soma and its potential for drug abuse.

Controlled Substances 52

Controlled Substances FDA 52

pharmaphorum

DECEMBER 27, 2024

Discover how Generative AI is revolutionising the pharmaceutical industry and moving beyond hype towards widespread adoption in drug discovery and development. Learn more about the impact of GenAI.

64

64

Drug Topics

DECEMBER 29, 2024

Check out this list of our top 5 most read womens health stories from the year 2024.

98

98

Pharmaceutical Technology

JANUARY 2, 2025

Severe asthma is traditionally classified into either high or low T-helper cell type 2 (T2) subtypes.

59

59

The Checkup by Singlecare

DECEMBER 31, 2024

Prednisone is a medication used to decrease irritation and inflammation in the body. It belongs to a class of drugs called glucocorticoids. There are many different conditions that prednisone is used for, including allergies, asthma, dermatitis, inflammatory bowel disease, arthritis, lymphoma, and leukemia. Its even used for organ transplantation in adults.

Dosage 52

Dosage Immunization 52